Xerient
2 known investors
Xerient is developing therapeutic technology aimed at treating abdominal and gastrointestinal cancers, with a focus on pancreatic cancer. The company targets unmet needs in cancer treatment with the goal of improving patient survival.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Xerient do?
- Xerient is developing therapeutic technology aimed at treating abdominal and gastrointestinal cancers, with a focus on pancreatic cancer. The company targets unmet needs in cancer treatment with the goal of improving patient survival.
- Who are Xerient's investors?
- Xerient's investors include Peregrine Ventures, SIBF (Southern Israel Bridging Fund) VC.